Hereditary Angioedema Market Size And Share

  • Report Code : TIPRE00005410
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

유전성 혈관부종 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Hereditary Angioedema Market Report Hereditary Angioedema Market Scope and Analysis Hereditary Angioedema Market Size and Share

Hereditary Angioedema Market Report Analysis

Hereditary Angioedema Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BIOCRYST PHARMACEUTICALS, INC
  • CSL
  • Ionis Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp
  • Pharming Group N. V.
  • Sanofi N. V.
  • Shire plc.
  • Teva Pharmaceutical Industries, Ltd.
  • Attune Pharmaceuticals

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 약물
  • C1 에스테라제 억제제
  • 칼리크레인 억제제
  • 브래디키닌 수용체
  • 약독화 안드로겐
  • 기타
By 투여 경로
  • 피하
  • 정맥내
  • 경구
By 유통채널
  • 병원약국
  • 소매약국
  • 전자상거래
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미